Published in Health Risk Factor Week, May 3rd, 2005
Now, a new technology designed to deliver localized, non-radioactive radiation treatment directly to cancer sites may significantly increase access to radiation treatment and thus demand for breast-conserving therapy, according to a multidisciplinary panel of physicians here at the recently concluded 6th Annual Meeting of the American Society of Breast Surgeons (ASBS).
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Risk Factor Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.